Perhaps one of the more perplexing yet simultaneously intriguing wagers in the market, there’s no shortage of opinion on Carlotz (NASDAQ:LOTZ), the user-car dealership that’s threatening to disrupt the way Americans purchase secondhand vehicles. On one hand, a compelling bullish case exists based largely on the pandemic. However, economic concerns also weigh heavily on LOTZ
Daily Trade
Like the frustrated knights of Arthurian legend who tried to withdraw Excalibur from the magical stone that gripped it, many investors have struggled in vain to withdraw profit from a short sale of Tesla Inc. (NASDAQ:TSLA) stock. Source: Shutterstock None has succeeded, except perhaps for a few fleeting moments. Tesla has been defying all skeptics, naysayers, and
In late September, you could have purchased shares in Bionano Genomics (NASDAQ:BNGO) for a mere 27 cents a share. The company had been mostly marginalized on Wall Street. But things would suddenly change in a very big way. BNGO stock would go on to soar to a high of $15.69. Source: Connect world / Shutterstock.com
The commercial got a lot of attention when it aired during the Super Bowl. And it was definitely funny. Source: Shutterstock It just wasn’t exactly accurate. You probably saw the commercial. It featured well-known actor and comedian Will Ferrell, who was absolutely enraged because “Norway is out EVing us”… meaning beating us in electric vehicles.
The creation of stock market rules often comes after a big event happens. Some examples include the stock market crash of 1929 — which led to the wide-ranging federal securities laws — and the financial crisis of 2009. For the most part, regulators are reactive — there is usually not much effort to anticipate what
When I first got the editorial nod to discuss MicroVision (NASDAQ:MVIS), I initially thought that this was my first time writing about the company. Turns out, I had mentioned MVIS stock as one of the top micro-capitalization plays for 2017. Source: Shutterstock Yes, those were some good times. Back when I first wrote about the
After a strong day in the markets, stocks turned in a more muted session on Tuesday. Now, let’s see how the rest of the week shakes out while we look at a few top stock trades. By the way, did you see Rocket Companies (NYSE:RKT) today? I outlined that one yesterday, but wasn’t looking for
After a wild couple of weeks for growth stocks, March kicked off with the best one-day rally in months. There was more volatility again today, but the bottom line is that the major stock indices continue to trade near historic highs. Source: Shutterstock On today’s new episode of MoneyLine, I discuss the current market situation
Blue-chip stocks are normally steady and dependable. Investors can count on them to deliver reasonable returns and consistent dividend payments while keeping volatility low and stress to a minimum. However, several tried and true blue-chip stocks that otherwise performed well over the last 12 months are starting to look a little pale lately. Investor enthusiasm
On Friday, Hindenburg Research and Culper Research released scathing reports on SOS Ltd (NYSE:SOS), a Chinese cryptocurrency mining company. The two short-sellers claimed that SOS stock was an intricate “pump and dump” scheme that used fake addresses and doctored photos of crypto miners to create an illusion of success. Source: Kim Britten / Shutterstock.com SOS stock
I don’t believe there’s much value in the ophthalmology portfolio for Ocugen (NASDAQ:OCGN). The failure of OCU300, the company’s primary candidate, seemed to end the bull case for OCGN stock. Source: Shutterstock.com Ocugen does have other candidates, but as I wrote last year those candidates appear to require too much money and too much time
Since coming public via a direct listing in September, Palantir Technologies (NYSE:PLTR) has been on a wild ride. Consider that PLTR stock has gone from around $10 to a high of $45. Source: Sundry Photography / Shutterstock.com But lately, things have gotten choppy. Consider that PLTR stock is now trading at $23.96, with the market
After a long drought, Gevo (NASDAQ:GEVO) has seen its shares surge in value over the past four months. Reduced to penny stock status last summer, GEVO stock suddenly caught fire in November. After closing at $14.61 on Feb. 12, shares in this biofuels company gained 1,390% since Election Day. President Joe Biden’s green energy plan is
A lot of people claim to be the #1 Stock Picker in America… But few can back it up like Luke Lango. He’s #1 according to one of the most widely recognized financial ratings companies in the world. He beat out nearly 15,000 experts to claim that title. Luke’s the guy who uncovered peak gains
Hyliion (NYSE:HYLN) announced its earnings on Feb. 23, showing that the company had installed 20 truck hybrid electric vehicle (EV) units in 2020 as expected. But HYLN stock will move up or down in 2021 depending on how well it executes its commercialization plan. Source: Shutterstock This execution has to occur in 2021. HYLN will
The S&P 500 closed within a few ticks of all-time highs on Wednesday before taking a hit the next day. But it sure doesn’t feel that way for investors who have been making consistent money in high-growth sectors and stocks. Source: Shutterstock On today’s new episode of MoneyLine, I dive into the recent pullback in
Special purpose acquisition companies are one of the hottest trends on Wall Street right now. And there’s no one hotter than Chamath Palihapitiya, the so-called King of SPACs. Social Capital Hedosophia IV (NYSE:IPOD) is one of Palihapitiya’s suite of six different SPACs. And, so far, IPOD stock is off to a good start. It’s jumped
Clover Health Investments Corp. (NASDAQ:CLOV) has fallen to $9.71 as of Feb. 24 from $15.90 on Jan. 8 when its SPAC (special purpose acquisition company) merger closed. On Feb. 4, Hindenburg Research came out with a scathing research short report on CLOV stock and its founders and promoters. Source: Shutterstock I believe that the stock
With earnings season winding down, it’s time to look at what the results portend for a list of hot stocks that I believe are worthy of investment now. The results show that the fourth quarter of 2020 is the first final period since Q4 2019 to show year-over-year earnings growth. More S&P 500 Index companies
Microsoft (NASDAQ:MSFT) is firing on all cylinders. But MSFT stock still looks expensive. Source: Shutterstock Microsoft opened for trade Feb. 24 at about $230 per share. That’s a market cap of roughly $1.75 trillion on estimated fiscal 2021 revenue of $164.2 billion. The trailing price-earnings ratio is near 35. There’s nothing wrong with the company.